Improving Care and Access

DOCS Education funds research that opens new avenues for treating fearful patients.

Dental phobia leading to treatment avoidance is a worldwide problem. How can dentists return these individuals to oral health? DOCS Education’s Research & Development supports the increased availability of safe oral sedation, recognizing its role in the promotion of ongoing regular dental care.

The pharmacology of oral sedatives—most boast used in the outpatient dental setting is tested and sound. However, widespread agreement calls for the launch of more studies on patients in the dental practice. As practicing dentists and physicians, DOCS Faculty are uniquely qualified to contribute to this vital area, focusing upon research that improves care in the point where patients receive it


Our faculty are experienced practitioners who have witnessed the benefits of using oral conscious sedation in dentistry and believe in leading, developing or supporting studies that add to the body of knowledge about the subject.

Learn more about our impressive DOCS Education faculty.

Research Areas

Oral sedation in the treatment of children and teenagers. (Drs. Roger Sanger, Peter Chiang and Kenji Saisho)

Sublingual triazolam for the provision of anxiolysis in the dental setting. (Dr. Anthony Feck)

Publications and References

AGD Enteral Conscious Sedation Conference. Academy of General Dentistry GD White Paper on Enteral Conscious Sedation. Gen Dentistry. 2006(7)301-4.

Chowdhury J, Vargas KG. Comparison of chloral hydrate, meperidine, and hydroxyzine to midazolam regimens for oral sedation of pediatric dental patients. Pediatr Dent. 2005(3):191-7.

Dale O, Nilsen T, Loftsson T. Intranasal midazolam: a comparison of two delivery devices in human volunteers. J Pharm Pharmacol. 2006;58(10):1311-8.

Dionne RA, Yagiela JA, Silverman M. Balancing efficacy and safety in the use of oral sedation in dental outpatients. J Am Dent Assoc. 2006;137;502-513.

Dionne RA, Gordon SM, McCullagh LM. Assessing the need for anesthesia and sedation in the general population. J Am Dent Assoc. 1998;129;167-73.

Feck A, Goodchild J. Rehabilitation of a fearful dental patient with oral sedation: Utilizing the incremental oral administration technique. Gen Dentistry. 2005(2);22-6.

Goodchild J, Donaldson M. Calculating and justifying total anxiolytic doses of medications for in-office use. Gen Dentistry. 2006(3)54-7.

Goodchild J, Flanagan D. Comparison of triazolam and zaleplon for sedation of dental patients. Dentistry Today. 2005(9)39-6.

Gordon, SM. Evidence of safety for individualized dosing of enteral sedation. Gen Dentistry. 2007(5)410-5.

Gordon SM, Dionne, RA. Dental fear and anxiety as a barrier to accessing oral health care among patients with special health care needs. Journ Spec Care in Dentistry. 1998(3);20-9.

Jackson D, Milgrom, P, Heacox, G. Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. Journ of Clin Psychopharmacology. 2006(1):4-8.

Jackson D, Johnson, B. Inhalational and enteral conscious sedation for the adult dental patient. The Dental Clinics of North America. 2002(46);781-802.

Shapira J, Kupietzky A, Kadari A. Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients. Pediatr Dent. 2004(6);492-6.